AstraZeneca UK, Ltd. v. Atchley
Pending petition
Docket No. |
Op. Below | Argument |
Opinion |
Vote |
Author |
Term |
23-9 |
D.C. Cir. |
TBD |
TBD |
TBD |
TBD |
TBD |
Issues: (1) Whether the court should grant, vacate, and remand this case for further proceedings in light of its decision in Twitter, Inc. v. Taamneh; (2) whether plaintiffs plead proximate causation as required for direct liability under the Anti-Terrorism Act by alleging that defendants transacted with a foreign-government agency that was in turn infiltrated by the group that injured plaintiffs; and (3) whether a U.S.-designated foreign terrorist organization “plan[s]” or “authorize[s]” a specific attack—as required for ATA aiding-and-abetting liability—by providing general support or inspiration to a different group that carries out the attack.
Date | Proceedings and Orders (key to color coding) |
---|
Apr 03 2023 | Application (22A868) to extend the time to file a petition for a writ of certiorari from May 4, 2023 to July 3, 2023, submitted to The Chief Justice. |
Apr 06 2023 | Application (22A868) granted by The Chief Justice extending the time to file until July 2, 2023. |
Jun 30 2023 | Petition for a writ of certiorari filed. (Response due August 4, 2023) |
Jul 25 2023 | Motion to extend the time to file a response from August 4, 2023 to August 23, 2023, submitted to The Clerk. |
Jul 26 2023 | Motion to extend the time to file a response is granted and the time is extended to and including August 23, 2023. |
Aug 04 2023 | Brief amici curiae of Chamber of Commerce of the United States of America, et al. filed. |
Aug 23 2023 | Brief of respondents Joshua Atchley, et al. in opposition filed. |
Sep 06 2023 | DISTRIBUTED for Conference of 9/26/2023. |
Sep 06 2023 | Reply of petitioners AstraZeneca UK Limited, et al. filed. (Distributed) |
Oct 02 2023 | The Solicitor General is invited to file a brief in this case expressing the views of the United States. Justice Alito took no part in the consideration of this petition. |